Moleculin Biotech Inc (MBRX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.41
• Market Cap: $22.47M
• EPS: $-3.74
• 52-Week High: $33.00
• 52-Week Low: $2.25

Market Sentiment

Moleculin Biotech Inc currently has a Neutral sentiment score of -0.05.

About Moleculin Biotech Inc

Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company located in Houston, Texas, specializing in innovative therapies for cancer and viral infections. It is leveraging proprietary technology to advance a diverse pipeline of drug candidates designed to tackle highly resistant tumors and address significant unmet needs in oncology. With its commitment to scientific rigor and breakthrough treatments, Moleculin Biotech is well-positioned to make a substantial impact on the future of ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Moleculin Biotech Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MBRX pay dividends?

Moleculin Biotech Inc (MBRX) does not currently pay a regular dividend.

What is MBRX's market cap?

Moleculin Biotech Inc (MBRX) has a market capitalization of $22.47M with a current stock price of $2.41.